SEOUL (Reuters) - South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing. The pharmaceutical company said the first in-human clinical trials of the ...
from Google Alert - health https://ift.tt/2XkCDpN
via IFTTT
0 comments:
Post a Comment